Profusa, Inc. Common Stock vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 4 of 6 compared factors.
Size & Scale
| PFSA | RMD | |
|---|---|---|
| Market Cap | $228,059 | $32.38 billion |
| Revenue (TTM) | — | $5.65 billion |
| Net Income (TTM) | $-36,563,000 | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| PFSA | RMD | |
|---|---|---|
| P/E Ratio | — | 21.13 |
| Price / Book | -0.01 | 4.92 |
| Price / Sales | — | 5.73 |
PFSA leads on 1 of 1 valuation factors.
Profitability
| PFSA | RMD | |
|---|---|---|
| Net Margin | — | 26.94% |
| Return on Equity | 129.67% | 23.13% |
PFSA leads on 1 of 1 profitability factors.
Dividend
| PFSA | RMD | |
|---|---|---|
| Dividend Yield | — | 1.20% |
| Payout Ratio | — | 25.31 |
PFSA and RMD split the dividend factors evenly.
Risk & Sentiment
| PFSA | RMD | |
|---|---|---|
| Short Interest | 7.30% | 4.02% |
RMD leads on 1 of 1 risk & sentiment factors.
Dig deeper: PFSA overview, PFSA financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.